Skip to main content
    H

    HealthEquity Inc (HQY)

    Official site

    HEALTHCARE • HEALTH INFORMATION SERVICES • NASDAQ

    $104.58
    +1.12 (+1.08%)

    Market Cap: $8.56B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    HealthEquity Inc (HQY) Financials: Revenue, Profit and Cash Flow

    Updated Aug 27, 2026. Financial statements from company filings, amounts in US dollars.

    HealthEquity reported revenue of $1.31B for the fiscal year ended Jan 31, 2026, up 9.5% from the year before. That year, net income was $215.20M with a net margin of 16.4%, operating cash flow was $457.09M and free cash flow was $408.61M. The quarter ended Jul 31, 2026 had revenue of $350.73M and net income of $65.64M.

    Revenue and Margins

    The operating margin was 24.6% in the fiscal year ended Jan 2026. Over the 9 years to Jan 2026, revenue grew from $178.37M, a compound annual rate of 24.8%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Jan 2026$1.31B+9.5%69.5%24.6%16.4%
    Jan 2025$1.20B+20.0%64.8%13.5%8.1%
    Jan 2024$999.59M+16.0%62.3%11.8%5.6%
    Jan 2023$861.75M+13.9%57.1%1.1%-3.0%
    Jan 2022$756.56M+3.1%56.1%-3.2%-5.9%
    Jan 2021$733.57M+37.9%56.6%4.6%1.2%
    Jan 2020$531.99M+85.2%61.3%14.5%7.5%
    Jan 2019$287.24M+25.1%63.1%27.0%25.7%
    Jan 2018$229.53M+28.7%58.8%23.7%20.6%
    Jan 2017$178.37MN/A59.6%23.1%14.8%
    Annual, fiscal years ended Jan 2017 to Jan 2026

    Income Statement

    In the fiscal year ended Jan 2026, net income rose 122.5% from the year before. In the quarter ended Jul 2026, net income rose 9.7% from the same quarter a year earlier.

    Annual

    Line itemJan 2026Jan 2025Jan 2024Jan 2023Jan 2022Jan 2021Jan 2020Jan 2019Jan 2018Jan 2017
    Revenue$1.31B$1.20B$999.59M$861.75M$756.56M$733.57M$531.99M$287.24M$229.53M$178.37M
    Cost of revenue$400.31M$422.51M$376.95M$369.81M$331.79M$318.24M$206.08M$106.05M$94.61M$72.02M
    Gross profit$913.12M$777.26M$622.64M$491.94M$424.76M$415.33M$325.91M$181.19M$134.92M$106.36M
    Research and development$262.51M$239.51M$218.81M$193.38M$157.36M$124.81M$77.58M$35.06M$27.39M$22.38M
    Operating income$322.46M$162.33M$117.70M$9.06M-$24.24M$34.01M$77.01M$77.67M$54.42M$41.21M
    Net income$215.20M$96.70M$55.71M-$26.14M-$44.29M$8.83M$39.66M$73.90M$47.36M$26.38M
    EBITDA$490.28M$341.19M$286.43M$174.79M$111.47M$160.03M$125.99M$94.33M$68.42M$53.40M
    Fiscal years ended Jan 2017 to Jan 2026

    Quarterly

    Line itemJul 2026Apr 2026Jan 2026Oct 2025Jul 2025Apr 2025Jan 2025Oct 2024Jul 2024Apr 2024Jan 2024Oct 2023
    Revenue$350.73M$354.64M$334.59M$322.16M$325.83M$330.84M$311.82M$300.43M$299.93M$287.60M$262.39M$249.22M
    Gross profit$257.95M$256.31M$228.15M$228.06M$232.59M$224.31M$189.04M$197.03M$204.05M$187.14M$163.32M$159.18M
    Operating income$98.69M$102.95M$71.07M$78.69M$89.61M$83.08M$42.15M$19.63M$58.93M$41.63M$38.89M$30.89M
    Net income$65.64M$69.42M$49.74M$51.69M$59.85M$53.91M$26.36M$5.70M$35.82M$28.81M$26.36M$14.67M
    Last 12 quarters

    Balance Sheet

    As of Jan 2026, total debt of $967.29M exceeded cash and equivalents by $648.36M.

    Annual

    Line itemJan 2026Jan 2025Jan 2024Jan 2023Jan 2022Jan 2021Jan 2020Jan 2019Jan 2018Jan 2017
    Total assets$3.38B$3.45B$3.16B$3.09B$3.11B$2.71B$2.56B$510.02M$369.16M$279.14M
    Current assets$512.28M$477.75M$557.44M$382.89M$351.34M$460.18M$297.30M$394.68M$265.40M$200.82M
    Cash and equivalents$318.93M$295.95M$403.98M$254.27M$225.41M$328.80M$191.73M$361.48M$199.47M$139.95M
    Total liabilities$1.27B$1.33B$1.13B$1.19B$1.25B$1.33B$1.53B$32.94M$22.89M$17.20M
    Short-term debt$9.91M$10.00M$9.40M$17.50M$8.75M$62.50M$39.06M$0N/AN/A
    Long-term debt$957.38M$1.06B$874.97M$907.84M$922.08M$924.22M$1.18B$0$0$0
    Shareholder equity$2.11B$2.11B$2.04B$1.90B$1.85B$1.38B$1.03B$477.08M$346.27M$261.94M
    Fiscal years ended Jan 2017 to Jan 2026

    Quarterly

    Line itemJul 2026Apr 2026Jan 2026Oct 2025Jul 2025Apr 2025Jan 2025Oct 2024Jul 2024Apr 2024Jan 2024Oct 2023
    Total assets$3.27B$3.31B$3.43B$3.40B$3.42B$3.42B$3.45B$3.49B$3.51B$3.25B$3.16B$3.09B
    Total liabilities$1.28B$1.26B$1.32B$1.26B$1.27B$1.29B$1.33B$1.36B$1.36B$1.15B$1.13B$1.11B
    Cash and equivalents$256.00M$265.37M$318.93M$309.26M$304.46M$287.89M$295.95M$322.16M$326.89M$251.23M$403.98M$334.06M
    Shareholder equity$1.99B$2.05B$2.11B$2.13B$2.15B$2.12B$2.11B$2.12B$2.16B$2.10B$2.04B$1.99B
    Last 12 quarters

    Cash Flow

    In the fiscal year ended Jan 2026, free cash flow was 89.4% of operating cash flow. Share repurchases came to 73.2% of it.

    Annual

    Line itemJan 2026Jan 2025Jan 2024Jan 2023Jan 2022Jan 2021Jan 2020Jan 2019Jan 2018Jan 2017
    Operating cash flow$457.09M$339.86M$242.83M$150.65M$141.00M$181.62M$105.01M$113.42M$81.70M$45.59M
    Capital expenditures$48.48M$53.21M$42.82M$48.54M$71.62M$64.59M$32.94M$13.88M$15.84M$12.68M
    Free cash flow$408.61M$286.64M$200.01M$102.11M$69.38M$117.03M$72.07M$99.54M$65.86M$32.92M
    Share repurchases$299.25M$121.49M$0$0N/AN/AN/AN/AN/AN/A
    Investing cash flow-$47.14M-$505.45M-$46.07M-$119.13M-$639.25M-$96.96M-$1.74B$25.65M-$36.75M-$13.05M
    Financing cash flow-$386.98M$57.57M-$47.04M-$2.67M$394.86M$52.42M$1.47B$22.93M$14.56M$23.78M
    Fiscal years ended Jan 2017 to Jan 2026

    Quarterly

    Line itemJul 2026Apr 2026Jan 2026Oct 2025Jul 2025Apr 2025Jan 2025Oct 2024Jul 2024Apr 2024Jan 2024Oct 2023
    Operating cash flow$136.16M$97.53M$117.92M$138.57M$135.87M$64.74M$75.75M$90.55M$108.13M$65.43M$77.07M$57.11M
    Capital expenditures$15.77M$16.29M$10.07M$11.09M$11.18M$16.14M$13.56M$12.87M$12.96M$13.83M$11.27M$12.16M
    Free cash flow$120.39M$81.23M$107.84M$127.49M$124.69M$48.59M$62.19M$77.69M$95.17M$51.60M$65.80M$44.95M
    Last 12 quarters

    Frequently Asked Questions About HQY

    What is HealthEquity's annual revenue?

    HealthEquity reported revenue of $1.31B for the fiscal year ended Jan 31, 2026.

    How fast is HealthEquity's revenue growing?

    Revenue was up 9.5% for the fiscal year ended Jan 31, 2026 compared with the year before. The compound annual revenue growth rate over 3 years was 15.1%.

    Is HealthEquity profitable?

    Yes. HealthEquity reported net income of $215.20M for the fiscal year ended Jan 31, 2026, with a net margin of 16.4%.

    How much free cash flow does HQY generate?

    For the fiscal year ended Jan 31, 2026, operating cash flow of $457.09M minus capital expenditures of $48.48M produced free cash flow of $408.61M.

    How much debt does HealthEquity have?

    The balance sheet dated Jan 31, 2026 reported long-term debt of $957.38M, short-term debt of $9.91M and cash and equivalents of $318.93M.